NCT03204591 is a clinical trial of No intervention in Cirrhosis, Liver, sponsored by The Zhejiang Study Group for Organ Failure in Cirrhosis.

Who is sponsoring NCT03204591?

NCT03204591 is sponsored by The Zhejiang Study Group for Organ Failure in Cirrhosis.

What drugs are being tested in NCT03204591?

Interventions in NCT03204591: No intervention.

What condition does NCT03204591 study?

NCT03204591 studies Cirrhosis, Liver, Bacterial Infections, Acute Liver Injury.

Is NCT03204591 still recruiting?

NCT03204591 is currently status unknown. Last updated 6 June 2018.

Last reviewed 2018-06-06 · How we verify

NCT03204591

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bacterial Infections in Cirrhotic Patients With Acute Severe Liver Injury

Status unknown Last updated 6 June 2018

What this trial tests

trial testing No intervention in Cirrhosis, Liver in 500 participants. Status unknown.

Timeline

20 July 2017

Primary endpoint
18 October 2018

18 January 2019

Quick facts

Lead sponsor	The Zhejiang Study Group for Organ Failure in Cirrhosis
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	500
Start date	20 July 2017
Primary completion	18 October 2018
Estimated completion	18 January 2019
Sites	1 location across China

Drugs / interventions tested

No intervention

Conditions studied

Cirrhosis, Liver — all drugs for Cirrhosis, Liver →
Bacterial Infections — all drugs for Bacterial Infections →
Acute Liver Injury — all drugs for Acute Liver Injury →

Sponsor

The Zhejiang Study Group for Organ Failure in Cirrhosis

Who can join

Eligibility, any sex, with Cirrhosis, Liver or Bacterial Infections. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Acute hepatic insults including hepatitis flare-up, active alcohol assumption and hepatotoxic drug use are common in patients with cirrhosis especially in Eastern countries.These patients are at high risk of developing acute-on-chronic liver failure (ACLF) and associated with high short-term mortality. And the natural history of these patients is frequently complicated by bacterial infections, which lead to deterioration of underlying diseases. The present study is aimed to investigate the prevalance and risk factors of bacterial infections in those patients and its impact on in-hospital/short-term mortality.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting

Other recruiting trials for Cirrhosis, Liver

Currently open trials in the same condition.

NCT07286643 — Echocardiography-guided Cirrhosis and Liver Failure-Intensive Care Protocol Sepsis · NA · recruiting
NCT06871111 — The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial · Phase 1 · recruiting
NCT07122700 — Evaluation of Non-Invasive Tests for Metabolic Liver Disease · recruiting
NCT07051369 — Frequency of Portal Hypertension Among Patient With Cirrhotic Liver With Ultrasound · active not recruiting
NCT06908785 — Utility of ROTEM® for Risk Stratification of Post-Invasive Procedure Hemorrhage in Patients With Cirrhosis (CIR-ROTEM) · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03204591 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The Zhejiang Study Group for Organ Failure in Cirrhosis
Last refreshed: 6 June 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03204591.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing